Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.42B | 12.07B | 11.74B | 9.75B | 9.68B | 8.49B |
Gross Profit | 11.87B | 12.07B | 11.90B | 9.75B | 9.68B | 8.49B |
EBITDA | 1.75B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 4.85B | 5.06B | 4.93B | 3.59B | 3.83B | 2.27B |
Balance Sheet | ||||||
Total Assets | 636.81B | 623.36B | 584.70B | 594.84B | 570.35B | 552.16B |
Cash, Cash Equivalents and Short-Term Investments | 44.04B | 50.64B | 51.36B | 62.70B | 49.89B | 39.20B |
Total Debt | 200.54B | 120.58B | 188.27B | 190.28B | 183.66B | 182.48B |
Total Liabilities | 606.44B | 590.92B | 553.48B | 563.44B | 536.85B | 518.42B |
Stockholders Equity | 30.37B | 32.44B | 31.23B | 31.40B | 33.49B | 33.73B |
Cash Flow | ||||||
Free Cash Flow | 4.66B | 383.00M | -6.97B | 21.57B | 17.17B | -1.83B |
Operating Cash Flow | 5.31B | 906.00M | -6.47B | 21.98B | 17.59B | -1.34B |
Investing Cash Flow | -2.94B | -2.92B | -535.00M | -629.00M | -380.00M | -1.01B |
Financing Cash Flow | -3.73B | -2.35B | -4.01B | 17.86B | -4.93B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $74.72B | 12.96 | 11.19% | 3.43% | 3.60% | 22.68% | |
76 Outperform | $69.36B | 9.72 | 20.49% | 6.36% | 5.44% | 2.81% | |
73 Outperform | $52.92B | 10.18 | 15.58% | 6.50% | -15.06% | ― | |
72 Outperform | $64.84B | 12.69 | 10.06% | 3.85% | 3.47% | -8.90% | |
69 Neutral | $69.81B | 10.74 | 11.64% | 4.46% | 1.10% | 32.55% | |
67 Neutral | $17.26B | 11.31 | 10.36% | 3.95% | 10.54% | 1.63% | |
65 Neutral | $77.34B | 13.25 | 8.69% | 2.51% | -2.22% | 24.37% |